KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Pharmaceuticals (ACAD) Debt to Equity: 2010-2012

Historic Debt to Equity for Acadia Pharmaceuticals (ACAD) over the last 1 years, with Mar 2012 value amounting to $0.00.

  • Acadia Pharmaceuticals' Debt to Equity was N/A to $0.00 in Q1 2012 from the same period last year, while for Mar 2012 it was $0.00, marking a year-over-year change of. This contributed to the annual value of $0.00 for FY2011, which is 47.87% down from last year.
  • According to the latest figures from Q1 2012, Acadia Pharmaceuticals' Debt to Equity is $0.00, which was down 8.66% from $0.00 recorded in Q4 2011.
  • Acadia Pharmaceuticals' 5-year Debt to Equity high stood at $0.00 for Q4 2010, and its period low was $0.00 during Q2 2011.
  • Its 3-year average for Debt to Equity is $0.00, with a median of $0.00 in 2011.
  • Data for Acadia Pharmaceuticals' Debt to Equity shows a maximum YoY slumped of 47.87% (in 2011) over the last 5 years.
  • Over the past 3 years, Acadia Pharmaceuticals' Debt to Equity (Quarterly) stood at $0.00 in 2010, then slumped by 47.87% to $0.00 in 2011, then reached $0.00 in 2012.
  • Its Debt to Equity stands at $0.00 for Q1 2012, versus $0.00 for Q4 2011 and $0.00 for Q3 2011.